This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Dermatology Remove Development Remove Drug Trials Related Topics
Clinical Development Clinical Trials Doctors Trials Gene Regulation Drugs Research Vaccine Vaccination More Related Topics >
article thumbnail

Scleroderma drug trial shows up to 60% improvement

Drug Discovery World

NOVEMBER 30, 2023

It is important to advance safe and effective treatments through clinical development, given the limited therapeutic options for scleroderma patients. I look forward to collaborating with the company in the FT011 development program ahead.”

Drug Trials 59
Drug Trials Trials Drugs Clinical Trials 59
article thumbnail

Scepticism in press over Kintor’s COVID-19 US drug trial

pharmaphorum

MAY 14, 2021

China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. Kintor is in talks with the Brazilian health regulator Anvisa about a further trials.

Drug Trials 52
Drug Trials Trials Drugs Dermatology 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024